These 4 Measures Indicate That Ipsos (EPA:IPS) Is Using Debt Reasonably Well

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. Importantly, Ipsos SA (EPA:IPS) does carry debt. But the real question is whether this debt is making the company risky.

Advertisement

Why Does Debt Bring Risk?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, plenty of companies use debt to fund growth, without any negative consequences. When we examine debt levels, we first consider both cash and debt levels, together.

Check out our latest analysis for Ipsos

What Is Ipsos's Debt?

You can click the graphic below for the historical numbers, but it shows that Ipsos had €397.6m of debt in December 2023, down from €454.7m, one year before. However, it also had €277.9m in cash, and so its net debt is €119.7m.

debt-equity-history-analysis
ENXTPA:IPS Debt to Equity History May 11th 2024

How Healthy Is Ipsos' Balance Sheet?

According to the last reported balance sheet, Ipsos had liabilities of €705.2m due within 12 months, and liabilities of €614.9m due beyond 12 months. Offsetting this, it had €277.9m in cash and €742.8m in receivables that were due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by €299.4m.

Given Ipsos has a market capitalization of €2.80b, it's hard to believe these liabilities pose much threat. However, we do think it is worth keeping an eye on its balance sheet strength, as it may change over time.

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

Ipsos's net debt is only 0.36 times its EBITDA. And its EBIT easily covers its interest expense, being 17.9 times the size. So we're pretty relaxed about its super-conservative use of debt. While Ipsos doesn't seem to have gained much on the EBIT line, at least earnings remain stable for now. When analysing debt levels, the balance sheet is the obvious place to start. But it is future earnings, more than anything, that will determine Ipsos's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. So the logical step is to look at the proportion of that EBIT that is matched by actual free cash flow. Over the last three years, Ipsos recorded free cash flow worth a fulsome 91% of its EBIT, which is stronger than we'd usually expect. That puts it in a very strong position to pay down debt.

Our View

The good news is that Ipsos's demonstrated ability to cover its interest expense with its EBIT delights us like a fluffy puppy does a toddler. And the good news does not stop there, as its conversion of EBIT to free cash flow also supports that impression! Zooming out, Ipsos seems to use debt quite reasonably; and that gets the nod from us. While debt does bring risk, when used wisely it can also bring a higher return on equity. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. To that end, you should be aware of the 1 warning sign we've spotted with Ipsos .

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MI
mitchell_lawler
mitchell_lawler

Is Nvidia actually expensive at 32 times earnings? I think that number can melt faster than people realise.

Is Nvidia actually expensive at 32 times earnings? I think that number can melt faster than people realise. cover
119
MA
marcus_l38oa

Why would I fret over Nvidia results now? I think it's moment has gone. I will invert and see what companies can be the next Nvidia.

SE
sean_3pk06

Multiple has already melted 50 percent in the last year. It can melt another 50 percent from here in the next year?

Mitchell Lawler

Which payment stocks actually get paid?

Which payment stocks actually get paid? cover
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
42

About ENXTPA:IPS

Ipsos

Through its subsidiaries, provides survey-based research services for companies and institutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Flawless balance sheet, undervalued and pays a dividend.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$522.6% undervalued
70 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5861.7% undervalued
55 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
49 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11632.3% undervalued
12 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

IN
LEXX logo
InvestingNurse on Lexaria Bioscience ·

Lexaria Bioscience's Breakthrough with DehydraTECH to Revolutionize Drug Delivery

Fair Value:US$2352.0% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
3156 logo
AstrisCorporateAdvisory on Restar ·

Monitoring next steps

Fair Value:JP¥2.59k96.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
prajeeshprathap
MEDP logo
prajeeshprathap on Medpace Holdings ·

Why Medpace Outperforms Competitors in the Mid-Sized Biotech Niche

Fair Value:US$53615.5% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28025.1% undervalued
358 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9118.2% overvalued
206 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.2% undervalued
230 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

Feedback welcome!

3
|
0
MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0
AL
BUSER logo
AlfredB on Bambuser ·

Very Intresting Times for Bambuser

1
|
0